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Abstract
Background:  Mammalians gamete production takes place in the testis but when they exit this organ, although
spermatozoa have acquired a specialized and distinct morphology, they are immotile and infertile. It is only after their
travel in the epididymis that sperm gain their motility and fertility. Epididymis is a crescent shaped organ adjacent to the
testis that can be divided in three gross morphological regions, head (caput), body (corpus) and tail (cauda). It contains
a long and unique convoluted tubule connected to the testis via the efferent ducts and finished by joining the vas deferens
in its caudal part.
Results: In this study, the testis, the efferent ducts (vas efferens, VE), nine distinct successive epididymal segments and
the deferent duct (vas deferens, VD) of four adult boars of known fertility were isolated and their mRNA extracted. The
gene expression of each of these samples was analyzed using a pig generic 9 K nylon microarray (AGENAE program;
GEO accession number: GPL3729) spotted with 8931 clones derived from normalized cDNA banks from different pig
tissues including testis and epididymis. Differentially expressed transcripts were obtained with moderated t-tests and F-
tests and two data clustering algorithms based either on partitioning around medoid (top down PAM) or hierarchical
clustering (bottom up HCL) were combined for class discovery and gene expression analysis. Tissue clustering defined
seven transcriptomic units: testis, vas efferens and five epididymal transcriptomic units. Meanwhile transcripts formed only
four clusters related to the tissues. We have then used a specific statistical method to sort out genes specifically over-
expressed (markers) in testis, VE or in each of the five transcriptomic units of the epididymis (including VD). The specific
regional expression of some of these genes was further validated by PCR and Q-PCR. We also searched for specific
pathways and functions using available gene ontology information.
Conclusion: This study described for the first time the complete transcriptomes of the testis, the epididymis, the vas
efferens and the vas deferens on the same species. It described new genes or genes not yet reported over-expressed in
these boar tissues, as well as new control mechanisms. It emphasizes and fulfilled the gap between studies done in rodents
and human, and provides tools that will be useful for further studies on the biochemical processes responsible for the
formation and maintain of the epididymal regionalization and the development of a fertile spermatozoa.
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Background
Spermatozoa are produced in the testis as the result of a
complex assembly line that makes a highly shaped cell,
morphologically and biochemically specialized. These
cells are released in the seminiferous tubules fluid and
then begin a long journey by "floating" passively through
the rete testis to leave the testis, entering the efferent ducts
and thereafter moving to the unique epididymal duct. Tes-
ticular spermatozoa are non functional, it is solely before
reaching the end of the epididymis, (where they will be
stored from days to weeks upon the species) that they will
acquire their physiological functions: the possibility of
motility, of undergoing the post-ejaculatory events (ie,
capacitation and hyperactivation), the ability to recognize
and to bind to the oocyte investments and plasma mem-
brane, and in short their natural fertilizing ability [1,2].
This post-testicular maturation results from changes in the
sperm membrane composition and metabolism in
response to the profound alterations of the surrounding
fluid composition. The fluid components (ions, chemi-
cals, lipids and proteins) are changing all along the differ-
ent ducts through which the sperm transit [2-4]. It is now
well established that the sperm changes are progressive
and occur in a define order. Among the main transforma-
tions, the changes in the sperm surface proteins have been
extensively described [2,5-7]. A number of sperm surface
components are removed or altered during the transit
while others are added in relation with the fluid changes.
Some of these surface component changes have been
involved in the sperm egg recognition but these compo-
nents and therefore their mechanisms of modification are
not "universal" since they are not found in all mammals
(i.e. Fertilin-alpha which is involved in mouse sperm-egg
recognition but is a pseudogene in human) [8-11]. More-
over mouse knockout approaches to prove their role in
fertilization has been found tedious since the absence of
one component during spermatogenesis or sperm epidi-
dymal maturation may result in improper formation of
specialized sperm membrane surface domains [9,12,13].
These strongly suggest that multispecies studies are neces-
sary to better understand the common as well as species-
specific mechanisms involved in the sperm maturation
process and fertility.
The epididymal secretome and proteome of several mam-
malian species including pigs as well some of the mecha-
nisms involved in the sperm surface alteration have been
recently described [14-18]. The complete sequencing of
several mammalian genomes and the possibility open by
technologic progresses allow now analyzing the complete
gene expression of a tissue by microarray. Nowadays more
than ten different transcriptomic studies of mouse, rat and
human epididymis have been achieved [19-25]. These
studies have shown that a large number of genes are
expressed in the epididymis but only few genes were
found specifically over-expressed in this organ compared
to other tissues. Meanwhile they have also showed that a
high level of regionalization of the expression of part of
these genes existed and that this gene expression (and
hence protein secretions) is tightly regulated by the hor-
monal status and also by very specific local mechanisms
present either in the fluid within the tubule and/or may be
by action from the embedded fluid surrounding the
tubule in a specified zone delimited by the connective sep-
tae of the supporting tissue [23,25]. However, none of
these studies have included a comparison with testicular
gene expression and with the vas efferens and vas deferens
transcriptomes and the human studies have been limited
to the three gross morphological parts of the epididymis
(caput, corpus, cauda). Here we have used a microarray
approach to analyze the transcriptome of nine defined
regions of adult fertile boar epididymis, efferent and def-
erent ducts and testis. These epididymal regions were cho-
sen according to previous studies done on this species
[1,26].
Pigs provide good model for biomedical research, as pigs
and humans show in many aspects physiological, bio-
chemical, pathological and pharmacological similarities.
Recently it has been demonstrated that the porcine and
the human genome evolutionary distance is smaller than
the distance between mouse and human [27]. For exam-
ple a survey using a pig 20 000 genes cDNA microarray
indicated that gene expression in common porcine tissues
is very similar to the expression in homologous tissues of
human [28]. This provides a rationale to use porcine
sequences in gene expression comparisons with human in
transcriptomic analysis. Moreover, pig tissues are more
easily available than their human counterparts and several
pig microarrays have been made available to screen for
genes involved in specific biological processes of interest
such as diseases or development, but also related to the
agronomical interest for this species [29] since pigs are
one of the most eaten animals in the world today and the
pig industry will use more and more genetic selection
based on the development of marker-assisted selection
that rely on the mastering of artificial insemination tech-
niques, including the sperm fertility.
This study then fulfill the gap between the rodent and
human by addressing a domestic species with an agro-
nomical interest where the epididymal duct measure
more than 50 meters long and the transit of the sperm is
at least three weeks.
We have used a microarray that was made from clones
issued from a multi-tissue cDNA normalized library
including the testis and the three main gross regions
(caput, corpus, cauda) of the epididymis [30]. We have
also adapted specific statistical methods to analyze the
gene clustering and procedure to obtain genes that wereBMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
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over-expressed in specific transcriptomic units. Our data
showed the expression of several new genes in the epidi-
dymis and confirmed that very few epididymal specific
genes existed. Meanwhile a certain number of genes have
a very tight expression in one or a few zones and then
could be useful as markers for the epididymal activity and
some of these genes will also certainly be good candidates
to further understand the very specific biochemical proc-
esses involved in epididymal regionalization and to
obtain fertile spermatozoa.
Results
Differentially expressed transcripts between 12 conditions
The extracted mRNAs from the 12 different samples (tes-
tis, vas efferens, epididymis (zones 0 to 8/9) and vas defer-
ens (Figure 1)) were retro-transcribed in presence of 33P-
labelled oligonucleotide and hybridized onto the Nylon
microarray spotted with PCR products from clones from a
multi-tissues bank including reproductive tissues from
male and female [30]. Each PCR product contained also a
short sequence used to estimate the quality of the mem-
brane and to measure the quantity of each clone spotted.
This last value was used to correct the signal after hybrid-
ization with the 33P-cDNA.
After cleaning and digital processing of our array data, for
each tissue sample only spots with at least 3 valid repli-
cates were kept to estimate the intra-group variability. We
then retained 7676 valid spots throughout the 48 mem-
branes and 12 samples studied.
In order to determine the differential expression of a tran-
script between the twelve different tissue samples, each
was compared to the other for these 7676 spots with a
moderated F-test from the Limma R package (p-value
threshold after BH correction was 0.00001). Between the
12 tissue samples, 2115 transcripts showed a differential
expression. At this step, we expected that the main house-
keeping genes or the genes that were expressed at the same
level in all the tissues tested have been removed from the
analysis.
Transcriptional units
We first analyzed how these 2115 differentially expressed
transcripts could classify our biological samples. A cluster-
ing of the 12 tissue conditions was then performed with
the combinative use of the PAM and the HAC. The PAM
gives a graphic profile to help in the choice of the number
of classes, which is a critical step in unsupervised methods
(Figure 2A). In this figure, the quality of the classification
(measured by the mean silhouette width) is dependent on
the number of classes chosen. The higher is the value of
the mean silhouette width; the better is the quality of clas-
sification. In our case as it could be expected, the best fit
Boar epididymis Figure 1
Boar epididymis. Picture of the boar epididymis showing 
the different regions sampled: VE, vas efferens; 0 to 8/9, epidi-
dymis; VD, vas deferens. Reel size, 30 cm.BMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
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was for two classes (testis versus the other tissues), but this
was poorly informative from a physiological point of
view. We then decided to retain the second best score with
7 classes. Figure 2B shows how the arrays are clustered
within these 7 classes with the score obtained for each
array.
The result obtained by the HAC analysis is shown in Fig-
ure 2C. It was possible to find a threshold on the dendro-
gram to retrieve the 7 clusters grouping the same tissue
arrays as the PAM. By combining the results of these two
methods, the 7 clusters that fit the best our data of gene
expression correspond to: (i) the testis, (ii) the efferent
ducts, (iii) the anterior caput of the epididymis (zones 0–
1), (iv) the median caput (zone 2), (v) the posterior caput
(zones 3–4), (vi) the corpus (zones 4–7) and (vii) the cau-
dal region with the zone 8/9 and the deferent duct. We
also observed that some uncertainties exist for some
arrays, certainly due to animal variations: one epididymal
zone 2 membrane was classified in the posterior caput
Statistical analysis Figure 2
Statistical analysis. A) PAM outcome: the graph shows the mean width of clusters depending on the number of zones 
included in the cluster. B) Silhouette width (clustering score) of each of the seven transcriptomic units chosen for the cluster-
ing using the best second score of the PAM algorithm. C) Dendrogram obtained for the clustering of the 12 zones by HAC 
algorithm. The blue line cuts the dendrogram to retrieve the 7 transcriptomic units. D) Graph of PAM outcome showing the 
mean width of clusters depending on the number of clusters for transcripts. E) Clustering score (silhouette width) obtained 
for transcripts corresponding to the second best score of the PAM. F) Heat map representation of the transcripts clustering 
obtained by HCL algorithm. The blue line at the top cuts the dendrogram to show the 7 transcriptomic units and the green line 
on the left cuts the dendrogram to retrieve the 4 clusters of transcripts. (Relative expression level: yellow = high, blue = low; 
white = missing values). T: Testis, VE: Vas efferens, E0 to E8/9: nine epididymal zones, PC: Proximal caput, MC: Median caput, 
DC: Distal caput, VD: Vas deferens.
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while some zone 4 membranes were clustered within the
corpus unit instead in the posterior caput as expected.
Co-expressed transcripts
With the combinative use of the PAM and the HCL, we
analyzed how many co-expression classes could be
formed by the 2115 differentially expressed transcripts
(Figure 2). With the PAM the best classification of co-
expressed transcripts gave again two main clusters: the tes-
ticular transcripts versus the other tissues transcripts (Fig-
ure 2D). The classification with the second best score gave
4 clusters. As shown in Figure 2E, for each transcript a
value was associated which represents how the transcript
fits in the classes, the higher is the value the better this
transcript is representative of this class. The HCL analysis
showed also two main branches (testicular transcripts ver-
sus the other tissues transcripts) and we were able with a
threshold to separate 4 clusters identical to the PAM (Fig-
ure 2F). Then the analysis of the transcripts co-expression
defined four main classes: (i) the testis, (ii) the head of the
epididymis, (iii) the corpus and (iv) the efferent ducts and
the caudal region (E8/9 and deferent duct). The heat map
from the HCL (Figure 2F) showed the intensity of each co-
expressed transcripts within a cluster; some of them had
only a very small differential expression or could have
biphasic expression.
From these results, the identifier of each transcript from
each cluster were used to build a contingency table to
establish a list of robust transcripts classified the same way
by the two different algorithms (Table 1). Among the
2115 differentially expressed transcripts and the 12 tissue
conditions, 1772 (83%) are clustered in the same way by
the two statistical methods used. Among them, 774
(36%) transcripts have a preferential expression in the tes-
tis, 226 (11%) in the head of the epididymis, 453 (21%)
in the corpus and 319 (15%) in the efferent ducts and the
caudal region (zone 8/9 and deferent duct). 343 (17%)
transcripts were not classified the same way by the two
methods.
Search for preferentially over-expressed transcripts 
between the 7 transcriptomic units
The clustering analysis has shown that our 12 tissue con-
ditions formed 7 informative transcriptomic units. Mean-
while the gene analysis showed only four classes of co-
expressed genes. We then decided to dig further our data
to determine which transcripts are preferentially over-
expressed in only one of the transcriptional units. To do
this, we used parwise moderated t-tests from the SMVar
package [31] (for more detailed explanations see materi-
als and methods). We first searched iteratively for tran-
scripts differentially expressed between 2 transcriptomic
units with the pairwise moderated t-test, then for each
unit, we selected over-expressed transcripts using the
value of the logRatio expression obtain during the test.
Then, we compared between units, the list of over-
expressed transcripts and retained only those belonging to
one single list. Doing this, we selected, for each transcrip-
tomic unit, transcripts that are preferentially over-
expressed compared to the others. This was done on the
7676 usable spots and the 7 informative transcriptomic
units. The results of this test are summarized in Figure 3:
1243 unique transcripts have a preferential over-expres-
sion in one of these units.
Meanwhile, because we knew that some genes could be
expressed both in the testis and also in the epididymis (ie,
clusterin, PTGDS [5,32,33]), these genes may be elimi-
nated by our analysis although they are over-expressed in
one unit of the epididymis. The analysis was then redone
in excluding the testis: we then found that 631 transcripts
were over-expressed in only one of the 6 remaining units.
We have also done the same approach excluding both the
testis and the vas efferens that may have a partially different
embryonic origin than the epididymis [34,35], and found
558 transcripts over-expressed in one of the epididymal
units.
Because including the testis and the vas efferens in our
analysis had consequence on numbers of transcripts
retrieved as epididymal, we performed a second analysis
on the 7676 qualified spots without these tissues. The
Limma moderated F-test (BH p-value threshold of
0.00001) gave 850 transcripts differentially expressed
between the nine epididymal zones and the vas deferens.
When we compared this new list with the list of differen-
tially expressed transcripts between the 12 conditions, we
observed that 838 transcripts were common and only 12
were new ones. The classification on the nine epididymal
zones and the vas deferens was performed with 2 algo-
rithms (PAM and the HAC) gave 5 tissue clusters corre-
sponding to (i) the anterior caput of the epididymis
(zones 0–1), (ii) the median caput (zone 2), (iii) the pos-
terior caput (zones 3–4), (iv) the corpus (zones 4–7) and
(v) the caudal region (zone 8/9) including the vas deferens.
A clustering of co-expressed transcripts with the combina-
tive use of the PAM and the HCL on the 850 differentially
expressed transcripts found only 3 clusters: (i) the head of
the epididymis, (ii) the corpus, (iii) the caudal region.
Table 1: Search for common co-expressed transcripts
Cluster HCL PAM Common transcripts
Testis 794 850 774
Caput 250 398 226
Corpus 702 463 453
VE/Cauda 369 404 319
Common transcripts are those clustered in the same way by the HCL 
and PAM algorithms.BMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
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A contingency analysis showed that 721 transcripts
among the 850 are clustered in the same way by the 2 sta-
tistical approaches used. Among them, 220 have a prefer-
ential expression in the head of the epididymis, 343 in the
corpus and 158 in the caudal region (zone 8/9 and vas def-
erens).
Search for potential markers (testis, vas efferens, 
epididymis)
Numerous genes were found over-expressed in more than
one tissue. As we were interested to find more specific
genes and functions related to these genes, we decided to
search for "markers". Markers are then defined as tran-
scripts that are over-expressed preferentially in the same
transcriptomic unit where the clustering analysis classified
them. By this way, we do not keep as markers transcripts
that have a biphasic expression profile. By crossing the
data, for the testis 459 potential markers were found, for
the efferent ducts 33, for the anterior head 116 (zones E0-
1), for the median head (zone E2) 8 potential markers, for
the posterior head (zones E2-3-4) 14, for the corpus
(zones E4-5-6-7) 90 and for the cauda (zone E8/9 and def-
erent duct) 43 transcripts (See List in Additional File 1).
Validation of microarray by semiquantitative RT-PCR and 
real-time PCR
We have selected 20 different transcripts found as differ-
entially expressed by the clustering analysis and then
designed primers (Additional File 2) and measured the
relative amplicon intensities obtained after 25, 30, 35 and
40 cycles of RT-PCR amplification.
Almost all transcripts were found effectively expressed
within the transcriptomic unit assigned by the statistical
approach (Figure 4). Only for RAP1A, which had a very
low expression level on microarray, it was not possible to
observe the differential expression by RT-PCR. This figure
also confirms that some of the genes have a bi-phasic
expression: they were both expressed in the testis and in
one transcriptomic unit of the epididymis. These genes
could then be found over-expressed in one unit when the
statistical analysis was done on the twelve conditions but
like CRABP1 or AWN, become part of an epididymal clus-
ter when the analysis was done without the testis and the
vas efferens (10 tissue conditions). As control we also
amplified two genes (RERG  and APLP2) that were not
found in the common list of the two statistical approaches
but had a statistically significant differential expression on
microarray. Again the results of microarray and RT-PCR
were in agreements.
We also analyzed the beta 2-microglubulin (B2M) gene
that was not found differentially expressed. The primers
for this gene were designed in such way that they were on
two successive exons. The RT-PCR showed only the waited
amplicon of 189 bp (instead of 757 bp when the intron is
included) indicating also the absence of genomic DNA
contamination. As predicted this gene showed no differ-
ential expression by PCR whatever the number of PCR
cycles.
Among the transcripts, we have also chosen for each one
of our transcriptomic units, one gene found as a marker
Over-expressed transcripts Figure 3
Over-expressed transcripts. Number of over-expressed transcripts in an unique transcriptomic unit for each of the 7 tran-
scriptomic units found by the clustering analysis (BH = 1/100 000). Analysis was done with all transcriptomic units (7 units), 
without testis (6 units) and without testis and vas efferens (5 epididymal units). *compared results obtained with 5 versus 7 tran-
scriptomic units.
7 transcriptomic units 6 transcriptomic units 5 transcriptomic units
Percentage change in 
epididymal transcripts number*
Testis 547
Vas efferens 48 52
Proximal caput 155 144 151 -3%
Median caput 12 13 14 17%
Posterior caput 50 59 65 30%
Corpus 318 264 212 -33%
Cauda 113 99 116 3%
Epididymal transcripts 648 579 558 -14%
Total of overexpressed transcripts 1243 631 558BMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
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RT-PCR amplifications Figure 4
RT-PCR amplifications. RT-PCR amplifications of some transcripts differentially expressed or control (ie, not differential) 
between the 12 or 10 zones studied. T: Testis, VE: Vas efferens, PC: Proximal caput (E0-1), MC: Median caput (E2), DC: Distal 
caput (E3-4), Corpus (E4-7), Cauda (E8/9 and Vas deferens (VD)), (-): negative PCR controls. The table on right indicated the 
number of PCR cycles used and the cluster in which the transcript belongs by the clustering analysis using 12 or 10 zones. NC: 
transcripts were not classified in an identical manner by the two methods (PAM and HCL), NA: transcripts were not statisti-
cally differentially expressed. INSL3 (insulin-like 3), INHA (inhibin, alpha), CLU (clusterin), METTL7B (methyltransferase like 7B), 
RARRES2 (retinoic acid receptor responder (tazarotene induced) 2), TEDDM1 (Transmembrane epididymal protein 1), SPP1 
(secreted phosphoprotein 1), TSPAN1 (tetraspanin 1), GPX5 (glutathione peroxidase 5 (epididymal androgen-related protein)), 
HEXA (hexosaminidase A (alpha polypeptide)), RAP1A (RAP1A, member of RAS oncogene family), CPE (carboxypeptidase E), 
CES7 (carboxylesterase 7), MAN2B2 (mannosidase, alpha, class 2B, member 2), MUC1 (mucin 1, cell surface associated), AWN 
(sperm associated AWN protein), CRABP1 (cellular retinoic acid binding protein 1), RERG (RAS-like, estrogen-regulated, 
growth inhibitor), APLP2 (amyloid beta (A4) precursor-like protein 2), B2M (beta-2-microglobulin).
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by the statistical analysis (INSL3, METTL7B, CE9 (homol-
ogous to putative membrane protein HE9),  SPP1,
TSPAN1, CPE, AWN). The expression of these genes was
measured by the intensity of the amplicon on gel after RT-
PCR on the twelve different tissues (as in Figure 4), and
the validity of the statistical analysis compared after aver-
aging the results to reproduce either the seven or the five
transcriptomic units where these genes have proved to be
over-expressed and classified (Figure 5). The expression
level of these genes was also quantified by real-time PCR
and all the results compared to the expression values from
the microarray (Figure 5). All PCRs and microarrays
results were in very close agreements. For METTL7B,
which was found as a vas efferens marker, a slight discrep-
ancy exists between the microarray and the PCR data. This
difference came from the fact that among the four boars
the one chosen for the PCR showed the highest expression
in zone zero (not shown). Meanwhile when the level of
PCR expressions is mathematically pooled to reproduce
the seven tissue clusters, this gene expression was clearly
higher in the vas efferens compared to the proximal caput.
Expression pattern of gene families of interest
Among the transcripts found in the clusters, some of them
belong to families that have been previously described in
different epididymal studies. So, we further studied the
expression pattern in boar of some of these genes and
their related family genes found on our array.
a) Lipocalins
Several lipocalin family members have been described in
the epididymis and found in the epididymal fluid [36].
We found that clones with related sequences to 7 known
lipocalins (APOD, PTGDS, LCN5, LCN6, LCN8, UCAL-
P19) and one uncharacterized lipocalin (UNQ2541) were
spotted on the microarrays and showed a differential
expression. We designed primers (Additional File 2) and
we compared the results of the microarrays hybridization
and RT-PCR expression levels (Figure 6). We obtained a
very good matching for APOD,  PTGDS,  LCN5,  LCN6,
LCN8, while the differential presence of UNQ2541 was
observed in caput with a maximum in zone 1. For UCAL-
P19 (named uterocalin in horse [37]) a low signal was
found all along the epididymis by PCR, suggesting a low
level of expression for this gene and the differential
expression could not be confirmed. We have also ana-
lyzed the LCN2 gene expression because this gene is also
named Uterocalin in database although there is no
sequence homology with UCAL-P19  (see discussion).
LCN2 expression was detected in boar epididymis but did
not show a differential expression (Figure 6).
b) Defensins
Specific expression of a large number of defensins has
been shown by previous epididymal transcriptomic stud-
ies [20,21,38]. The data mining of the clone sequences
spotted on our pig microarray showed that at least 7
defensin genes were present and differentially expressed
(DEFB109,  DEFB111,  DEFB113,  DEFB121,  DEFB129,
SPAG11B_C, SPAG11B_E). The identity of each of these
pig defensins was ascertained by sequence comparisons
and cysteine positions and spacing (Figure 7H to 7N, and
Figure 7O). Five of these defensins were already correctly
described in pig (DEFB111,  DEFB121,  DEFB129,
SPAG11B_C, SPAG11B_E) and two were miss-annotated
(DEFB111, DEFB121). We also identified two new boar
defensins homologous to DEFB109 and DEFB113.
By RT-PCR, the 7 defensins were found exclusively
expressed in the caput and corpus epididymis (Figure 7).
DEFB109 is mainly restricted to the anterior caput (Figure
7A) while SPAG11B_C, DEFB121, DEFB111 genes had a
high relative expression in that region with a smaller
expression in the posterior caput (Figure 7B–D). DEFB113
had a high relative expression in the caput through zones
0 to 2 (Figure 7E). SPAG11B_E was expressed in all caput
zones with a maximum in the posterior caput epididymis
(Figure 7F) while DEFB129 (Figure 7G) was found mainly
in corpus (zones 5–6) with expression in adjacent zones
(4 and 7).
c) Whey acidic containing domain proteins (WAPs)
Like lipocalins and defensins, WAP protease inhibitors
have been found in epididymis [39,40]. We identified
WFDC2, WFDC3, SLPI and a new WAP domain sequence
that we named WFDC10A-like since it shows similarities
to mouse and human putative protease inhibitor
WFDC10A (Figure 8E–H). WFDC3 was mainly expressed
in the testis (Figure 8A) while SLPI was expressed in vas
efferens and zone 0 (Figure 8B). WFDC2 had a low expres-
sion in the testis and all along the epididymis including
the vas deferens but with a highest level in the corpus and
cauda (Figure 8C). The WFDC10A-like  gene showed a
more restricted expression from the posterior caput to the
vas deferens with a maximum in the distal corpus and
cauda (zones 6 and 7; Figure 8D).
Expression pattern of some new epididymal genes or genes 
not yet described in boar
a) New variants of known genes
Several cystatins have been shown mainly expressed in
epididymis and Cystatin 11 (Cst11) is an "epididymal spe-
cific" gene expressed in the caput and corpus region in
mouse [41,42]. A variant with a deletion (Cst11 2) has
been suggested from "in silico" genomic sequence analy-
sis but not shown in vivo [43]. We found two clones over-
expressed in our microarray experiments with matching
sequence with CST11  and one of these clones had a
sequence deletion (Figure 9E and 9F). We designed prim-
ers encompassing the deletion and the RT-PCR confirmed
the presence of two amplicons at the expected sizes (247
bp and 169 bp respectively). The sequencing of theseBMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
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Comparison of relative expression of selected transcripts on microarray, PCR and realtime PCR Figure 5
Comparison of relative expression of selected transcripts on microarray, PCR and realtime PCR. A-C-E-G-I-K-
M: Relative expression of selected transcripts obtained from microarray, PCR (from Figure 4) and realtime PCR. Each value is 
expressed as a percent of the total intensity measured in the 12 samples studied (see materials and methods). In black, micro-
array values (each data is the mean of the data from the 4 boars studied), in white RT-PCR values and in grey Q-PCR values 
(values were obtained from one of the boar used in the microarray study). T: Testis, VE: Vas efferens, 0 to 8/9: nine epididymal 
zones, VD: Vas deferens. B-D-F-H-J-L-N: Relative expression measured in the 12 samples studied were averaged to repro-
duce either the 7 or 5 transcriptomic units for which some transcripts have been defined as markers. Microarray, RT-PCR and 
Q-PCR values are in black, white and grey respectively (T: Testis, VE: Vas efferens, PC: Proximal caput (E0-1), MC: Median 
caput (E2), DC: Distal caput (E3-4), CP: Corpus (E5-6-7), CD: Cauda (E8/9-Vas deferens).
INSL3
%
 
o
f
 
t
o
t
a
l
 
i
n
t
e
n
s
i
t
y 80
40
60
TV D 8/9 7 6 5 4 3 2 1 0 VE
20
A
50
40
30
20
10
METTL7B C
TV D 8/9 7 6 5 4 3 2 1 0 VE
%
 
o
f
 
t
o
t
a
l
 
i
n
t
e
n
s
i
t
y
20
40
60
CE9 E
%
 
o
f
 
t
o
t
a
l
 
i
n
t
e
n
s
i
t
y
TV D 8/9 7 6 5 4 3 2 1 0 VE
20
30
10
SPP1 G
%
 
o
f
 
t
o
t
a
l
 
i
n
t
e
n
s
i
t
y
TV D 8/9 7 6 5 4 3 2 1 0 VE
20
40
10
30
TSPAN1 I
%
 
o
f
 
t
o
t
a
l
 
i
n
t
e
n
s
i
t
y
TV D 8/9 7 6 5 4 3 2 1 0 VE
20
10
30
CPE K
%
 
o
f
 
t
o
t
a
l
 
i
n
t
e
n
s
i
t
y
TV D 8/9 7 6 5 4 3 2 1 0 VE
40
20
60
AWN M
%
 
o
f
 
t
o
t
a
l
 
i
n
t
e
n
s
i
t
y
TV D 8/9 7 6 5 4 3 2 1 0 VE
INSL3
%
 
o
f
 
t
o
t
a
l
 
i
n
t
e
n
s
i
t
y
TC D CP DC MC PC VE
B
80
40
60
20
20
40
60
METTL7B D
%
 
o
f
 
t
o
t
a
l
 
i
n
t
e
n
s
i
t
y
TC D CP DC MC PC VE
20
40
60
80
CE9 F
%
 
o
f
 
t
o
t
a
l
 
i
n
t
e
n
s
i
t
y
TC D CP DC MC PC VE
20
40
60
SPP1 H
%
 
o
f
 
t
o
t
a
l
 
i
n
t
e
n
s
i
t
y
CD CP DC MC PC
20
30
40
10
TSPAN1 J
%
 
o
f
 
t
o
t
a
l
 
i
n
t
e
n
s
i
t
y
CD CP DC MC PC
20
60
40
CPE L
%
 
o
f
 
t
o
t
a
l
 
i
n
t
e
n
s
i
t
y
TC D CP DC MC PC VE
20
60
40
80
AWN N
%
 
o
f
 
t
o
t
a
l
 
i
n
t
e
n
s
i
t
y
CD CP DC MC PCBMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
Page 10 of 29
(page number not for citation purposes)
Lipocalins expression Figure 6
Lipocalins expression. A to H: Relative expression of the different lipocalins studied: APOD (apolipoprotein D), PTGDS 
(prostaglandin D2 synthase), UCAL-P19 (uterocalin), LCN5 (lipocalin 5), LCN6 (lipocalin 6), LCN8 (lipocalin 8), UNQ2541 
(uncharacterized lipocalin UNQ2541/PRO6093 precursor),LCN2 (lipocalin 2). On the top of each graphic the image of agarose 
gel used for amplicon quantifications is shown. In black, microarray values (means of the data from the 4 boars studied) and in 
grey RT-PCR values. T: Testis; VE: Vas efferens; 0 to 8/9: nine epididymal zones; VD: Vas deferens. Values represent the percent 
of total intensity measured in the 12 samples studied (see materials and methods).
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amplicons confirmed the existence of the two mRNAs. We
observed that although sCst11Δ had a lower intensity than
the full sCST11, both mRNAs were present in the same
zones with a same biphasic pattern of expression (Figure
9A and 9B).
Eg627821 (also named EST AV381130) was described in
mouse epididymis as a specifically caput/corpus over-
expressed gene [44]. DNA sequence analysis suggested
two possible peptide sequences by alternative RNA splic-
ing but only one mRNA was analyzed in this previous
study. We found two clones over-expressed showing both
a different deletion when compared to the mouse
sequence. We have ascertained the existence of both mes-
sengers by RT-PCR with specific primers and amplicon
sequencing (Figure 9G). We found that both mRNA were
equally expressed in posterior caput with a similar expres-
sion pattern (Figure 9C and 9D).
b) New unreported genes in boar
Among our over-expressed genes we choose two genes
that were not previously observed in epididymis and four
not yet described in boar.
Relative expression of defensins Figure 7
Relative expression of defensins. A to G: Relative expression of DEFB109 (defensin beta 109), SPAG11B_C (sperm associ-
ated antigen 11B isoform C), DEFB121 (defensin beta 121), DEFB111 (defensin beta 111), DEFB113 (defensin beta 113), 
SPAG11B_E (sperm associated antigen 11B isoform E), DEFB129 (defensin beta 129) is represented as the percent of total 
intensity obtained on microarray (black) and for some compare with the percent of total amplicon intensity measured on the 
12 samples studied (Grey). T: Testis, VE: Vas efferens, 0 to 8/9: nine epididymal zones, VD: Vas deferens. H to N: Comparison 
of the pig deduced amino acid sequences of each beta-defensin from different mammalian species. Amino acid residues that are 
identical between at least two sequences in alignments are placed in shaded boxes. Cysteins of the beta-defensin domain are in 
bold and for each protein, numbers of amino acids between the characteristic cysteins are reported in boxes. Hyphens repre-
sent gaps introduced for optimal alignment. O: Accession number of sequences used for alignments.
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SPINK5L2, a Kazal type serine protease inhibitor, is a
marker of the corpus with a maximum intensity in zones
6 and 7 (Figure 10A). MON1b, a new member of the
SAND protein family, was also expressed in the cauda
(Figure 10B). FXYD2, the gamma subunit of the Na, K-
ATPase, was found as a marker of the VE (Figure 10C).
GP2, Glycoprotein 2 (Pancreatic zymogen granule mem-
brane protein GP-2) gene not yet described in epididymis,
is highly expressed in the anterior caput in boar (Figure
10D). MUC15 is a novel mucin-like protein that is over-
expressed in the boar caput epididymis (Figure 10E).
GLB1L3 (Galactosidase, beta 1-like-3), is a new member
of the galactosidase beta family. We found a high expres-
sion of this enzyme in the boar testis but also a differential
expression in the epididymis with a maximum in corpus
(Figure 10F). For all of these genes we find a very good
agreement between microarray over-expressions and RT-
PCR results.
Protease inhibitors expression Figure 8
Protease inhibitors expression. A to D: Relative expression of WFDC3 (WAP four-disulfide core domain 3), SLPI (secre-
tory leucocyte peptidase inhibitor), WFDC2 (WAP four-disulfide core domain 2), UNQWAP (uncharacterised WAP four-
disulfide core domain protein) is represented as the percent of total intensity measured in the 12 samples studied by microar-
ray in black and by RT-PCR values (grey). T: Testis, VE: Vas efferens, 0 to 8/9: nine epididymal zones, VD: Vas deferens). On the 
top the image of the agarose gel used for quantification. E to H: Comparison of the amino acid sequences of deduced Whey 
Acidic Protein family from different mammalian species. Identical Amino acid residues between at least two sequences in align-
ments are placed in shaded boxes. Characteristic domains are boxed and residues of the WAP domain are in bold. Hyphens 
represent gaps introduced for optimal alignment. Accession number of sequences used for alignments are: E: Mus 
(NP_082237), Homo (CAC36106), Sus (unpublished), Bos (XP_001789331); F: Sus_A (translated from scac0031.l.24), Sus_B 
(P22298), Mus (NP_035544), Homo (NP_003055), Bos (XP_590087); G: Sus (NP_999112), Homo(NP_006094), Bos 
(NP_001069958), Mus (NP_080599) and H: Mus (NP_001012741), Sus (translated from BX915529), Homo (NP_542791).
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Gene Ontology
We have associated the proper GO terms from the Gene
Ontology Consortium annotation categories for each
gene (biological processes, cellular components, and
molecular functions) and generated a list of over-repre-
sented GO terms using either the five transcriptomic clus-
ters or only the three epididymal clusters. From this
analysis, several over-represented categories were identi-
fied (Figure 11). As expected, and as a good internal con-
trol, "spermatogenesis" was one of the functions
associated with the testis, as well "cell division" and
"nucleus". (For list of genes related to these functions see:
Additional File 3 and Additional File 4)
Similar gene expression in mammals
Different epididymal transcriptomic studies have been
done in mouse, rat and human. Comparison of the data
between rat and mouse have been made and showed the
Gene variant analysis Figure 9
Gene variant analysis. A to D: Relative expression of CST11 (Cystatin 11 alternate transcript 1), CST11_Δ (Cystatin 11 
alternate transcript 2), Eg627821 (predicted gene, EG627821 alternate transcript 1),Eg627821_Δ (predicted gene, EG627821 
alternate transcript 2) is represented as the % of total amplicon intensity (grey) and corrected microarray values (black) meas-
ured in the 12 samples studied. T: Testis, VE: Vas efferens, 0 to 8/9: nine epididymal zones, VD: Vas deferens). On the top: image 
of agarose gels used for quantification. E: Comparison of nucleotidic sequences of Sus Scrofa CST11 alternate transcripts 
showing the primer positions used for amplification. Hyphens represent gaps introduced for optimal alignment. Numbers are 
residue numbers. Accession numbers for CST11 and CST11 Δ are respectively scac0028.a.13 and scac0036.l.15. F: Amino-acid 
sequences comparison between Sus Scrofa and Homo Sapiens CST11 isoforms showing that they have a different deletions. 
Amino acid residues that are identical between human and pig are shaded. Residues shown to belong to the cystatin domain by 
Pfam analyses are boxed and those characteristics of this domain are in bold. Accession numbers for hCST11, hCST11Δ are 
respectively NP_570612 and NP_543020. Amino acid sequences for sCST11 and sCST11_Δ are deduced from scac0028.a.13 
and scac0036.l.15 respectively. Hyphens represent gaps introduced for optimal alignment. G: Comparison of nucleotide acid 
sequences of Sus Scrofa Eg627821 alternate transcripts showing that both sequence have a different deletion. Arrows show 
the hybridization site of primers used for amplification. Accession numbers for Eg627821 and Eg627821_Δ are respectively 
BX924253 and BX922624. Hyphens represent gaps introduced for optimal alignment.
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difficulties to compare the different zones of these two
mammalians epididymis, even using similar microarray
technology [20,45]. In human, the main study was done
on three epididymal samples using the head, the corpus
and the cauda epididymis but no anatomical description
of this division was shown [22].
However, we tried to compare our data with those of these
three studies. We have first obtained the list of expressed
genes in the different studies. One obstacle to this com-
parison was the low level of gene annotation in boar or
homogeneity of genes annotation between species. To
encompass this problem, we have transformed all the
genes in their mus musculus homologous UniGene IDs. We
searched transcripts that have their higher level of expres-
sion for the 4 species studied, in the same epididymal unit
(caput, corpus, cauda) or in segments corresponding to
these units. For mouse, the 3 units were defined based on
anatomical and clustering information given by Johnston
et al., [21]. The caput was formed from segments 1 to 6,
corpus by segment 7 and the cauda segments 8 to 10. For
rat, the 3 units were defined from anatomical information
given by Jelinsky et al., [20]. The caput was composed by
segments 1 to 6, the corpus by segments 7 to 11 and the
cauda by segments 12 to 21. For human we used caput,
corpus, cauda defined in the Thimon et al., [22] study.
These data were compared to the boar over-expressed
genes list.
We then found that 768 mouse UniGene IDs were com-
mon between the 4 studies. Among these 768 genes IDs,
236 unigene IDs were found over-expressed both in one
region of boar and one of the regions of the three other
different species (57 in the caput, 131 in corpus and 48 in
cauda). Meanwhile when we looked for the common
over-expressed genes in the same unit in the four different
species we ended with only 8 IDs in the caput, 4 in corpus
and 35 in cauda (For the complete list of common gene
IDs see Additional File 5).
Gene deletion effect
Using the mouse homologous IDs found for our markers,
we search the MGI database for reproductive phenotypes
(Additional File 6). 46 of them were associated with a
reproductive phenotype, and 16 with male infertility. A
majority of these gene knockouts results in an impaired
sperm production associated with a poor sperm quality,
suggesting a testicular action. Meanwhile these genes were
not all markers of the testis in our study, may be indicat-
ing differences between mouse and pig. On another hand,
for some genes that were expressed both in testis and in
epididymis, the first effect of their knockout might be vis-
ible on the testicular function and then affect the sperm
formation, and in this case an effect on the epididymal
maturation becomes secondary or not visible.
Discussion
Here we used a 9 K Nylon microarray made during the
French AGENAE program which is spotted with 8931 PCR
amplified clones. Although this represents only a subset
of all genes expressed from the complete genome, one of
its advantages is that cDNA clones libraries from the testis
and the epididymis were included at the initial step of
normalization. Arrays were hybridized to compare gene
expression between the testis, vas efferens, nine epididymal
zones (0 to 8/9) and the vas deferens. The pig epididymis
is a large organ of more than 20 cm long containing about
50 meters of a convoluted tubule and its internal organi-
zation is much complex than in rodent. It is then more
difficult to individualize part of the boar epididymis
between connective tissue septae as it has been done in
mouse and rat [20,21]. Doing this will have been impos-
sible in a time-frame necessary to obtain samples from
one animal without mRNA degradation and this would
have conducted to analyze tens of different epididymal
segments which is time and money consuming. Moreover
previous study on pig secretome [5,26] and data obtained
in rodent suggested that much less transcriptomic units
might exist than anatomical separations imply. With pig
epididymis it is possible to obtain large samples, includ-
ing from the vas efferens that is more difficult in rodents.
Meanwhile anatomical differences between two individ-
ual boars may exist, and although we have drawn a special
attention to be very reproducible when collecting the sam-
ples from different animals, we observed some differences
in the gene expressions from some epididymal zones
between animals resulting in zones shuffling during
membrane clustering (see further). Because acquisition of
motility and fertility by the spermatozoa is progressive
along the epididymis and secretion of proteins is region-
alized, we postulated that genes expressed in a tight
regionalized manner might play a major role in this proc-
ess. For this reason we have focused our attention on dif-
ferentially expressed genes. In doing this we expected to
gain information on how this regionalization is main-
tained (common transcription factors controlling the
genes expressed in one transcriptomic unit), get clues on
specific mechanisms (clusters of genes involved in the
same physiological function) and deduced factors that
may be important in the sperm fertility acquisition and
epididymal regionalization. Then we have not analyzed
major known epididymal genes such as clusterin or
PTGDS since we already known that these genes are
widely expressed or present at several levels of the genital
tract. These genes that are over-expressed in more than
one epididymal transcriptomic unit may have important
roles for the cellular functions but may be not directly
related to the sperm maturation. Meanwhile the microar-
ray approach we used offer the possibility to analyze also
these genes, since they could be retrieved in the list ofBMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
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New genes in boar testis and epididymis Figure 10
New genes in boar testis and epididymis. A to F: Relative expression of SPINK5L2 (Kazal type serine protease inhibitor 
5-like 2), MON1B (MON1 homolog B), FXYD2 (FXYD domain containing ion transport regulator 2),GP2 (glycoprotein 2), 
MUC15 (mucin 15),GLB1L3 (galactosidase, beta 1-like 3) is represented as the % of total RT-PCR amplicon intensity (grey) 
measured in the 12 samples studied (T: Testis, VE: Vas efferens, 0 to 8/9: nine epididymal zones, VD: Vas deferens) and compare 
with the normalized microarray intensity values (black). On the top of the graphic the image of agarose gel used for quantifica-
tion.
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expressed genes that is deposed on the GEO database
(GSE15614).
Because our type of array is not widely used and the bio-
logical question more complicated than a simple compar-
ison between two conditions on the same tissue, few
statistical tools were available. We had then adapted clas-
sical microarray statistical approaches in order to compare
the different conditions with a low number of replicates.
We have also decided to cross the results from different
statistical analysis to ascertain and strengthen our results,
especially to define epididymal markers. Our analysis
found 2115 transcripts with a differential expression
between the 12 conditions; this represents about 24% of
the transcripts spotted and 27% of our 7676 qualified
spots. In rat about 13% (4000 genes) from the 30000
transcripts of the microarray were found highly regulated
along the epididymis and comparable results were
obtained in mouse and human.
Tissues clustering indicated a good biological reproduci-
bility since arrays from the same tissues from different ani-
mals clustered together with few exceptions where one
zone could shift from one cluster to the previous or the
following one. We did not observe an effect of the breed
induced by the 3/4LW-1/4Landrace boars. The clustering
procedure builds 7 informative tissue array clusters from
our data. The testis was always well separated from the
other tissues and the epididymal zones were clustered in
anterior-, median-, posterior-caput, corpus and cauda
(including the vas deferens). The vas efferens formed one
independent cluster.
In contrast, transcripts clustering defined only 4 different
co-expression clusters: testis was separated from the rest of
the tissues then vas efferens and cauda/vas deferens were
grouped together while two epididymal clusters, caput
and corpus, were formed. This clustering difference (7 tis-
sue clusters against 4 co-expressed transcript clusters)
could be explained by the number of objects included in
each analyze: for classifying the 48 microarrays the proce-
dure used 2115 transcripts, while transcripts were classi-
fied using only 3 or 4 values for each of the 12 different
tissues which reduced the statistical power of the analysis.
In that analysis vas efferens/cauda/vas deferens may have
been clustered together because they have some common
genes involved in common functions (see GO terms) such
as ions binding and transport, or response to the same reg-
ulatory factors (for ex: retinoic acid receptor RARRES2 or
steroid hormone receptor) or more strikingly gene such as
AWN that codes for a specific boar sperm associated pro-
tein described mainly in the seminal vesicle [46],
although it was also immunolocalized in rete testis and
on epididymal sperm [47]. Meanwhile the vas efferens
showed also a unique and different set of genes expression
in agreement with its mixed embryonic origin (embryonic
glomerulus and upper Wolffian duct) compared to the
epididymis (upper Wolffian duct) and the vas deferens
(middle Wolfian Duct) [35].
Gene ontology terms enrichment Figure 11
Gene ontology terms enrichment. For each clustering analysis, GO terms enriched in one of the 4 or 3 clusters of tran-
scripts are given. Terms that are common of the 2 clustering analyses are shaded. For muscle development and coated pit 
terms, the unit where the most genes encode for these terms is noticed in exponent.
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This discrepancy in the number of clusters between tissues
and transcripts has conducted us to analyze the data with
particular statistical approaches to assign specific differen-
tial transcripts for each of the 7 groups of microarrays. The
use of two different approaches has also allowed us to
strengthen our results and choose the transcripts with
more confidence. Moreover the search for differential
genes in each epididymal transcriptomic unit brought us
to re-do the analysis excluding testis and VE units. In
doing that, we increased the number of transcripts in
some of the epididymal clusters but this was not general
since some clusters have also lost some genes that became
non statistically significant over the epididymis as they
were when the testis or the vas efferens were included. This
approach also explains why some of the gene known to be
highly expressed by the boar epididymis were not found
in the list of markers; these genes were either expressed in
two different clusters (ie testis and epididymis) or their
high expression spanned over different adjacent clusters
and then they were not retained as differential between
the epididymal transcriptomic units. This was the case for
example for RNase 10 (formerly described as train A), pre-
viously found in the pig anterior caput [16], that was
found over-expressed in our array analysis exclusively
from zones 0 to 2 then in both anterior and median caput
clusters.
We have ended with lists of significant over-expressed
transcripts and markers for each of the tissue clusters that
were further used to validate our microarrays data. For
almost all transcripts chosen, we find a very good agree-
ment between the level of expression obtained either by
microarrays, RT-PCR and real time PCR. Among these
genes used for this validation we have selected a certain
number because information on expression in male
reproductive tract were available and we have also ana-
lyzed new genes and genes not yet reported in epididymis.
The first one was clusterin (CLU). The mRNA is present
both in the testis and the epididymis as well as different
isoforms of the protein. This protein as many different
functions (chaperone, lipid transport etc) but its exact role
in these organs is not yet known. This dual expression was
retrieved in boar by microarray and PCR, and CLU was
classified in our analysis in the testis due to its higher level
of expression in this tissue. This gene is expressed over
more than one transcriptomic unit of the epididymis (dis-
tal caput and corpus) where the protein secretion and
presence in the fluid has already been described [16,26].
INSL3 and INHA were genes already known to be testicu-
lar and were found over-expressed in the boar testis.
INSL3, expressed mainly in Leydig cells, mediates the first
phase of testicular descent and mutation of this gene leads
to cryptorchidism [48]. INHA  encodes for the inhibin
alpha subunit, mRNA and protein chain have been local-
ized to Sertoli cells, which is the major body source of this
protein.
For the anterior caput, the boar homologue to CE9
(canine epididymal 9 gene) was analyzed. This gene has
been found in the upper part epididymis of dog and
mouse epididymis (named ME9) but not in human epidi-
dymis [49,50]. It has been suggested that its expression is
regulated by luminal factors from the testis [51]. This gene
encodes for an integral membrane protein and no clear
function as been yet assigned.
GPX5 gene has also been extensively study in the epidi-
dymis where it codes for an androgen-dependent glutath-
ione peroxidase specific in the distal caput epididymis of
mouse and rat [49,52]. A role for sperm and epididymis
protection against oxidative stress has been suggested for
this enzyme. In pig this mRNA was shown caput epidi-
dymis specific where the protein has been found secreted
in the fluid [26,53]. In agreement with these results we
found GPX5 over-expressed in zones 0 to 3. Secreted Phos-
phoprotein One (SPP1, Osteopontin) is widely distrib-
uted and was found over-expressed in vas efferens and
caput and at a lower level in cauda epididymis. This pro-
tein is involved in different cellular processes such as cal-
cium transport, bone resorption and extracellular matrix
(ECM) remodeling. In rat, it has been expressed and local-
ized in testis, vas deferens, and caput epididymis where it
was found associated with cellular vesicles and may be
involved in fluid calcium depletion [54]. In bull seminal
plasma, this protein has been related to sperm fertility
[55]. In boar polymorphisms in the OPN  gene region
have been significantly associated with male fertility traits,
mainly motility and acrosome reaction [56].
MAN2B2 is a lysosomal type D-mannosidase secreted in
porcine epididymal fluid (135 kDa alpha-D-Mannosi-
dase) [57,58] and was found expressed and secreted only
in a narrow region between the caput and corpus epidi-
dymis while it is found mainly in the murine testis at the
spermatogonia level [59]. Recently a polymorphism in
this gene was associated with ovulation rate in a Meishan-
cross gilts population [60]. Our data confirmed that
MAN2B2 was mainly epididymal in boar with a caput-
corpus specific over-expression. Recently we have
described the CES7 carboxylesterase (also named cauxin
for carboxylesterase-like urinary excreted protein) in the
epididymal fluid of various mammals, and its mRNA was
found in ram corpus epididymis. Here we showed that
like in ram, CES7 expression is restricted to the corpus
epididymis where the protein was immunolocalized in
the boar fluid [17]. Carboxypeptidase E (CPE) is a pro-
hormone processing enzyme (such as pro-insulin, pro-
gonadotropin-releasing hormone and pro-opiomelano-
cortin) in neuro/endocrine cells and a peripheral mem-BMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
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brane protein of secretory granules where it plays also a
receptor role that directs the pro-hormone to the regu-
lated secretory pathway [61,62]. The expression of CPE
mRNA in both neural tissues and some non-neural tissues
has been shown during embryonic development [63] but
not reported in the reproductive tract. Interestingly CPE
gene is over-expressed in the corpus epididymis where the
main enriched GO terms are related to reticulum endo-
plasmic functions. Whether this region secreted specific
factors or hormones that need to be processed by carbox-
ypeptidase E remains to be elucidated.
We have also focused our attention on several gene fami-
lies that have been previously described in different epidi-
dymal studies.
Lipocalins are found in vertebrates, insects and plants.
They are involved in the transport or storage of hydropho-
bic and/or chemically sensitive organic compounds, espe-
cially vitamins, lipids, steroids and other secondary
metabolites [64]. Several lipocalins have been described
in epididymis such as the retinol-binding protein LCN5
(epididymal retinoic acid-binding protein, E-RABP)),
LCN6, LCN8, LCN9, LCN10 or the PTGDS (prostaglandin
D2 synthase) and numerous studies have shown their
regional intensities of expression both at mRNA and pro-
teins levels [65]. Their exact individual role in the epididy-
mal function is still unclear. Here we have studied some
of these lipocalins (LCN5,  LCN6,  LCN8,  PTDGS) and
shown their regional expressions in boar and we have
described new lipocalin members that were not yet
observed in mammalian epididymis (UCAL-P19  and
APOD (apolipoprotein D)) and a new lipocalin member
matching with the human UNQ2541 sequence. UCAL-19
is a 19 kDa lipocalin that has been described in the horse
endometrium before embryo attachment where it is
secreted abundantly suggesting a role between maternal
and foetal tissues dialogue [37]. This gene was improperly
name uterocalin since it has a different sequence from
mouse uterocalin (LCN2, neutrophil gelatinase-associ-
ated lipocalin NGAL) which is a 25-kDa lipocalin origi-
nally purified from human neutrophils and highly
expressed in rodent caput epididymis [65,66]. In boar
epididymis UCAL-P19 showed a differential expression by
microarray that could not be clearly confirmed by RT-
PCR, certainly due to its low level of expression. PCR indi-
cated also that, contrary to rodent, LCN2 had a low and
not differential expression in boar. Apolipoprotein D
(APOD), a 29-kDa glycoprotein associated with high-den-
sity lipoproteins, is predicted to be a member of the lipoc-
alin family based on its primary structure [67]. The
protein is multifunctional and has many different ligands.
It binds and transports small hydrophobic compounds
including sterols-derived molecules. Its mRNA has been
localized in numerous tissues including the testis. We
retrieved the testicular expression of this gene and showed
that it is also expressed more in the vas efferens and vas def-
erens than other epididymal regions. Human UNQ2541
sequence, for which no role or localization information is
available, was located on chromosome 9 close to a lipoc-
alins cluster containing LCN6,  LCN8  and  LCN10. Its
expression was very similar to LCN6 and LCN8 expression
in boar caput epididymis suggesting they could be con-
trolled by the same factors [36].
Defensins, a family of secreted antimicrobial cationic pep-
tides with molecular weights of 4–5 kDa, have a distinc-
tive sequence pattern of six to eight cysteine residues. They
are categorized into alpha-, beta-, and theta-defensins
according to the arrangement of their three-four disulfide
bonds [68,69]. Defensins peptides are the major antimi-
crobial proteins of innate immunity found in mammals
and it seems that in mammals defensins are mainly from
the alpha and beta classes. In human over 40 beta-
defensins ORF have been found (but only 4 characterized
at the peptide levels) and in rat and in mouse at least 42
and 52 genes and pseudogenes respectively were discov-
ered by genome scans [70]. Moreover, it is also demon-
strated that some defensin gene (such as SPAG11) are able
to use different exons to produce multiple isoforms of
beta-defensin-like sequences [71]. Specific expression of
numerous epididymal beta-defensins has been shown
and SPAG11 and recently DEFB126 have been found
associated with sperm and the latter is involved in attach-
ing sperm to the oviduct epithelia and may be involved in
sperm motility and capacitation [72,73]. In their study
Jelinsky et al. [20] analyzed 29 defensins by QPCR in
mouse and rat and showed that they had very similar
epididymal regionalization in these two species. Recently,
Sang et al. [74] in a blast search on pig EST described 12
beta-defensins and eight were found by RT-PCR in the
male reproductive tract including the epididymis (caput,
corpus, cauda) and the testis. pBD4, pBD108 were found
mainly in proximal epididymis while pBD3 was mainly in
cauda. pEP2C was found in testis and epididymis while
pBD104 and pBD2 only in testis. Other defensins were
also expressed (pBD114,  pBD123,  pBD129  (DEFB129),
pBD125) in testis and/or epididymis but without differen-
tial expression in this last tissue. We have ascertained the
identities by sequencing and cysteine motifs alignments
of the seven beta-defensin clones found spotted on our
microarray. Five of them showed an anterior caput over-
expression while the SPAG11B_E isoform had a posterior
caput expression. Only DEFB129 was found in corpus.
The discrepancy with the previous study could be
explained by the fact that these authors used a 45 cycles
RT-PCR that is certainly not as discriminative as our
microarray analysis. Moreover for this defensin and the
two other (DEFB109 and DEFB113), that were also ana-
lyzed by RT-PCR, we found a very good agreement withBMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
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the microarray data. Interestingly the expression profiles
of the defensin genes in boar were closely similar to those
observed in mouse and rat, even for the SPAG11B iso-
forms.
Proteases and proteases inhibitors have an important role
in proteins processing both in tissues, fluids and at the
sperm plasma membrane levels during the maturation
process. We have focused on several members of different
type of protease inhibitors. WAP protease inhibitors con-
tain the WAP four-disulfide core domain structure, a
motif first described in whey acidic protein present in the
milk of rats and mice. WAP motifs consist of about 50
amino acids with eight highly conserved cysteine residues
forming four disulphide bridges. Then WAP protease
inhibitors possess like defensins specific cystein motifs
and exhibit antimicrobial and antifungal activities (may
be due to this wap domain) indicating also a role in the
innate immunity [75,76]. Several inhibitors of this family
have been found in epididymis [39,77] such as WFDC2
(WAP four-disulphide core domain protein 2, HE4
[78,79]) and SPINLW1  (serine protease inhibitor-like
with Kunitz and WAP domains 1, EPPIN [80]) and may
play a role in sperm maturation and function. WFDC2
(HE4) is also over-expressed in different normal and
malignant tissues [79]. We found several wap domains
proteins in the clones spotted and we ascertained their
identity by sequence comparison. WFDC2  was mainly
found in caput epididymis in mouse and rat and it is a dis-
tal cauda epididymal gene in human. In boar, it is present
all along the epididymis with an over-expression in cauda.
WFDC3 is a testicular over-expressed gene in boar while it
is found in testis (round spermatids) and highly expressed
in caput/corpus in rat. SLPI is expressed in wide range of
tissue and it has been immunolocalized in human epidi-
dymis and found in seminal plasma. It has been shown
highly expressed all along the rat epididymis and slightly
in mouse [20,21]. In boar, SLPI appears as a specific vas
efferens gene. We analyzed also an uncharacterized WAP
domain-containing protein with an unknown function
mainly expressed in the boar cauda epididymis and that
was named WFDC10A-like  from the closest human
sequence found (WFDC10A). The exact role of all these
wap domains proteins as inhibitors in epididymis
remained to be elucidated as well as their potential role as
bacterial defenses. Interestingly, WFDC2,  WFDC3,
WFDC10A and SLPI are found on the same gene cluster in
human chromosome 20. The mouse WFDC10 homologu-
ous gene has also been found highly expressed in mouse
cauda epididymis [39].
Because a large number of gene are translated in several
spliced mRNAs coding for different proteins and this dif-
ferent spliced mRNAs may be differentially expressed
along the epididymis (i.e SPAG11), we analyzed two
genes for which spliced mRNA forms were found in our
data.
Cystatins are reversible inhibitors of cysteine proteases.
They are found in all living organisms and are involved in
various biological processes and also take part in disease
pathology [42,81]. Several cystatins have been shown
mainly expressed in epididymis such as Cst8 (CRES) in
proximal caput where it is secreted in the fluid [82]. Cysta-
tin 11 (CST11) known as CRES2 in mouse is a member of
the CST type 2 family. Its mRNA was identified in Macaca
epididymis where it is expressed almost exclusively in the
epididymis. The protein is most abundant in the initial
segment, but is detected throughout the epididymis and
on ejaculated sperm [43]. These authors indicated that a
spliced deletion form of this mRNA could exist (Cst11 2)
and both recombinant proteins were produced. Interest-
ingly both form of this protein exhibited antibacterial
activity. We found the full length and the deleted mRNAs
in our spotted clones, and observed by PCR that both
mRNA exist and were expressed in the epididymis. Both
had a very similar pattern of expression with two maxi-
mum (proximal caput and caput/corpus junction)
although the deleted transcript showed lower expression
intensity. This caput over-expression of CST11  is also
reported in mouse and in rat.
We also found in our microarray two clones that were
similar to the mouse EG627821 mRNA (previously EST
AV381130) that has been found in mouse epididymis
[44]. This gene has an unknown function. In pig, this
sequence matched two clones, both showing a different
deletion when compared to the mouse sequence. Both
mRNAs were ascertained by PCR and sequencing, they
showed similar level and pattern of expression in poste-
rior caput/corpus. The mouse mRNA was shown
expressed in caput epididymis only after puberty by real
time PCR and confirmed by transcriptomic study [44].
At least we have also analyzed newly discovered genes and
genes not yet reported in boar. The first one was
SPINK5L2, which is a putative Kazal type serine protease
inhibitor 5-like 2. SPINKs are a family of inhibitors with a
characteristic signature consisting of six consensus
cysteines forming three specific disulfide bonds [39]. Sev-
eral members of this inhibitor family have been shown to
have a differential expression in the mouse, the rat and the
human epididymis. Their protease targets in the epidi-
dymis remained elusive. Recently, as part of a cluster of
SPINK, five new SPINK members were identified includ-
ing SPINK5L2 [83]. None of these members had func-
tional annotation. We found that the mRNA of the pig
SPINKL5  homologue is highly expressed in the corpus
epididymis. We found also a gene that is similar to
MON1B, a SAND family protein. These proteins haveBMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
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recently been shown to function at the tethering/docking
stage of the vacuole fusion as a critical component of the
SNARE complex [84]. The MON1B gene is found over-
expressed in the corpus epididymis were it is known that
a high level of secretion takes place. FXYD2, also known
as the gamma subunit of the Na, K-ATPase, regulates the
properties of that enzyme. In mouse epididymal transcrip-
tome this gene was not reported and in rat it was found
mainly over-expressed in the cauda. In boar it is mainly in
the VE where it may play a role in fluid/ion balance.
GP2, Glycoprotein 2 (Pancreatic zymogen granule mem-
brane protein GP-2) gene encodes for a GPI-linked mem-
brane protein that plays an important role in assembly of
vesicular compartments targeted to apical plasma mem-
branes via regulated exocytosis. This gene was not found
differentially expressed in mouse, rat and human epididy-
mal transcriptome. MUC15 is a novel mucin-like protein
that showed structural characteristic of membrane-bound
mucins including an extracellular region with several
potential glycosylation sites, a putative transmembrane
domain, and a short cytoplasmic C-terminal. mRNA pres-
ence has been reported in human testis [85] and transcrip-
tomic study had shown it in human corpus epididymis
[22], but it was not reported in mouse and rat epididymis.
The galactosidase GLB1L3  mRNA was not previously
reported in epididymis but it is mainly found expressed in
testis and prostate using the ESTProfile viewer at NCBI.
The protein has recently been reported in mice acrosome
by proteomic study [86]. In boar it is present in testis and
shows a regional expression in corpus. This glycan-modi-
fying enzymes may play either a role in degalactosylation
of sperm surface and/or fluid glycoproteins observed dur-
ing epididymal transit [7].
The use of microarrays allows also analyzing differential
functions through the use of gene ontology terminology.
In boar it was difficult to use all the information due to
the few genes with a valid GO annotation. We had to
transform genes in their mouse, human, rat, dog or bull
homologous genes and retrieved when possible the GO
term associated. This results in the loss of a large number
of transcripts. However we were able to found several
functions over-represented in the different transcriptional
units when we compared them together. We analyzed the
functions either with four clusters including testis and vas
efferens  or only with clustered transcripts in the three
epididymal units. In testis our GO analysis revealed func-
tion related to gametogenesis, this is not surprising but
gave a good indication on the validity of our data and
analysis. As already described some function were com-
mon between the vas efferens and vas deferens (fluid and
ion transports), but the cauda and vas deferens had func-
tions specific and related to the extracellular matrix
remodeling. This enrichment in these GO terms has also
been observed in human, mouse and rat, suggesting that
an important plasticity of this region exists, may be related
to the storage of sperm in that part of the epididymis. In
the corpus the main terms were associated with genes
involved in the endoplasmic reticulum function and
membrane/vesicles trafficking, suggesting protein synthe-
sis and secretory/reabsorbtion pathways. In boar, immu-
nological and histological studies have described the
different pathways of secretion and reabsortion of vesicles
at the cellular level [5]. Although different types of vesicles
and mechanisms are involved in this process, a well-
developed Golgi apparatus system is mainly present in
distal corpus were the secretomic analysis had shown that
the most intense proteins are secreted and the number of
secreted proteins increases from the caput to the caput/
corpus region. This Golgi apparatus is still present in the
corpus where the number of secreted proteins remains
high. The finding that differential genes expressed
between caput and corpus with this GO term may imply
that a differential type of protein modifications occurs
between these two adjacent segments as it has been sug-
gested by the nature of the secreted proteins [5,15].
In the caput the main enriched term was receptor activity.
Receptors for different modulators such as activin, proges-
terone and FGF were present and among the 9 receptors
forming this category at least four were retinoic acid
responders. This is in agreement with previous studies in
rodent that have shown the important role of acid retinoic
in the functions of the caput epididymis [87]. Although
vas efferens was clustered with cauda and vas deferens, the
GO enriched term "coated pit" was associated with the VE.
This term was related with four different transcripts over-
expressed in this tissue with homology to
DAB2_HUMAN, LRP2_HUMAN, LRP1_HUMAN and
CUBN_MOUSE. LRP1 and LPR2 are members of the LDL
receptor family that plays diverse roles in various biologi-
cal processes including lipoprotein metabolism, degrada-
tion of proteases, activation of lysosomal enzymes, and
cellular entry of bacterial toxins and viruses. The presence
of low-density lipoprotein receptor-related protein-2
(LPR2) has been shown in mouse where LPR2 plays a role
in endocytosis of testicular clusterin by the vas efferens
[88]. Other testicular protein could also be removed by
this mechanism such as transferrin or apolipoproteins.
We noticed that three of the four genes (DAB2 (disable 2
protein),  LRP2  (megalin) and CUBN  (cubilin)) are
involved in vitamin D uptake, which is considered as a
steroidal hormone. The vitamin D metabolite
(25(OH)D3) is synthesized in the liver and circulate in
complex with its binding protein (DBP). The messenger
for this protein is present in boar testis and zone 2 of the
epididymis (Guyonnet et al., unpublished). The
25(OH)D3-DBP complex is internalized via receptor-BMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
Page 21 of 29
(page number not for citation purposes)
mediated endocytosis, which is absolutely dependent on
the membrane receptors megalin (LPR2), cubilin (CUBN)
and the adaptor protein disabled-2 (DAB2), the expres-
sion of these proteins is in turn modulated by retinoids
[89]. Once in the cell, the biologically active metabolite of
vitamin D, (1,25-dihydroxyvitamin D3; (1,25(OH)2D3))
is formed by action of the 1-alpha-hydroxylase (CYP27B1,
a cytochrome P450 enzyme) and binds to the vitamin D
receptor (VDR). We found that CYP27B1 is expressed all
along the boar epididymis and VDR is expressed in the
boar testis, vas efferens and epididymis (Guyonnet et al.,
unpublished). VDR has also been shown in mouse, rat
and rooster epididymis [90] as well as the intracellular
vitamin D binding interacting protein (Vdrip) that medi-
ates anchors of the complex to the estrogen receptor (ER)
and other nuclear receptors [91,92]. VDR can form
homodimer but also heterodimer with the retinoid X
receptor (RXR) present in the boar vas efferens (Guyonnet
et al., unpublished) and then regulates genomic expres-
sion of a large number of genes. Vitamin D plays a pivotal
role in maintaining serum calcium homeostasis by mod-
ulating calcium/phosphate absorption via its action on
calcium binding proteins, such as SPP1  (osteopontin)
that is over-expressed in boar VE and caput epididymis.
Vitamin D is also a regulator of the aromatase in female
and male gonad but also in the epididymis [91,93,94].
Interestingly ions and about 90% of the testicular fluid
reabsorbtion occur in the vas efferens region, and control
of these mechanisms by estrogen has been demonstrated
since ERalphaKO mice are infertile primarily due to a
defect in efferent ducts development and function related
to fluid reabsorbtion [95]. Recently, it has also been dem-
onstrated that (1,25(OH)2D3), stimulates the innate
immune response in antigen-presenting cells, like macro-
phages and dendritic cells but also in other cell types [96].
The 1,25-D/VDR complex bound to the retinoid X recep-
tor increases the endogenous defensin and cathelicidin
genes production [97,98]. At least, it was shown that male
rat with low vitamin D diet had a lower fertility due to
lower testicular sperm production but also poor sperm
quality [99].
All along this publication we referred to the previous
rodents and human epididymal transcriptomic studies in
order to compare the gene expression. We have developed
bio-informatic tools to compare information on gene
over-expression in the four different species and found
that a certain number of genes were over-expressed in the
four species in one of the three gross anatomical epididy-
mal regions. This low number of common genes in a sim-
ilar region was not too surprising. In their study Jelinsky
et al, [20] whom made a detailed comparison on both the
mouse and rat epididymal transcriptomes were strongly
limited due to the identification of orthologous sequences
present on arrays. Starting with more than 30.000 tran-
scripts, they "only" found 6198 orthologous genes; 3481
genes were determined to be expressed in the epididymi-
des of the 2 species and 492 were differentially expressed.
Among these 492 genes, 380 had similar expression pat-
terns in mouse and rat, and 112 were different.
Although we had a low number of common genes
between species, we analyzed the GO term associated with
the genes of each regions and found that in the caput six
genes formed a cluster with functions in cell and to cell
signaling and interaction (including some genes control-
led by RXR), in the corpus three genes with cell morphol-
ogy, assembly and development while in the cauda, two
main groups of genes formed first a network in cell to cell
signaling, morphology and connective tissue develop-
ment (24 genes) and a second including 11 genes
involved in cell death and endocrine system. This demon-
strated, if needed, that the epididymis is highly regional-
ized and this regionalization, regulated by the endocrine
system, shows also an important plasticity.
We did not attempt to do the same analysis with the tes-
ticular transcripts with different species. Meanwhile,
although both approaches were quite different, we com-
pared the list of the most intense transcripts from our
study with the one recently published in a differential
boar testis transcriptomic study between two breeds [29].
Among the 50 most intense differential genes reported by
these authors, we found only 5 transcripts matching the
top 50 most intense testicular transcripts of our analysis
(CYP17A1, ferritin light and heavy chain (FTL and FTHI),
CYB5, DHRS4).
Conclusion
In conclusion, the present study and transcriptomic stud-
ies in other species clearly demonstrated that the high
degree regionalization in epididymis is linked to the
regionalization of gene expression. This is also well in
agreement with the previous secretomic and fluid proteins
analysis. This regionalization appears as the results of a
specific and subtle regulatory mechanisms from the endo-
crine system involving androgens and also estrogens. Dif-
ferent studies suggested also a numbers of other
regulatory components such as retinoid derived from vita-
min A. Our study indicated that the vas efferens and the
caput might have a certain number of genes regulated by
retinoid receptors. Moreover our analysis suggests also
that secosteroids (such as vitamin D) certainly carried by
the testicular and epididymal fluid may have a role in the
efferent ducts and epididymal function. It is interesting to
note that in rat, epididymis presents the second body level
of this compound just behind the kidney [100]. Then the
relevance of the vitamin D as an intracrine-autocrine-
paracrine system in the epididymis needs to be further
analyzed.BMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
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All the transcriptomic studies have found that family of
genes such as defensins or different type of protease inhib-
itors are over-expressed in different places of the epidi-
dymis. These proteins have role in the innate immunity
response against infection from bacteria and fungus. The
presence of such large amount of these compounds may
be a necessity to reduce or prevent the presence in the
fluid or within the spermatozoa from cells of the immune
system that could after developed autoantibodies deleteri-
ous for reproduction. It is likely that different defensins
are much more than antimicrobial, and further functional
work will uncover different roles for what is increasingly
regarded as a multifunctional gene family. Anti-proteases
may also be involved in the regulation of the sperm and
fluid proteins processing that occurs during maturation
and are part of this maturation process.
At least all these transcriptomic studies allow us to see
through the high complexity and specialization of epidi-
dymis and differences between species. Numerous genes
are under the same common regulators and then could be
targets for future studies to understand the mechanisms
involved in epididymal regionalization and those impli-
cated in sperm maturation.
Methods
Animals
Four adult boars (2 Large White and 2 cross-breed Large
White-Landrace (3/4; 1/4)) aged from 18 to 36 months
were used in this study (average weight was 301 ± 17 Kg).
These animals were provided by insemination centers
where they were used for genetic improvement. For each
animal, different criteria of the semen quality (volume of
semen, spermatozoa concentration, spermatozoa mobil-
ity) were followed during their reproductive life and con-
sidered as good or very good. Their fertility calculated on
at least 150 artificial inseminations ranged from 88 to
94% (fertility 91.8 ± 3.2%; litter size 13.5 ± 0.2).
Sample collection
Experiments on animals were conducted according to the
French laws on animal experimentation (Authorization
37-081). The animals were sacrificed at our local slaugh-
terhouse and the testis and epididymis were removed after
bleeding. The testicle and epididymal weights were 626 ±
53 g and 135 ± 7 g respectively. The tissues were carefully
dissected in less than 30–40 min after the death of the ani-
mal in order to minimize the mRNA degradation. The
maximum of interstitial tissue and blood vessels were
removed from the tubule. Samples from the testis, vas effe-
rens (VE), nine define epididymal zones (zero to 8/9) and
vas deferens (VD) were snap frozen and used further for
mRNA extraction (Figure 1). The epididymal zones were
identified anatomically according to morphological and
physiological criteria [7]. At the morphological scale,
changes in the diameter of tubules and cellular composi-
tion of epithelium along the different zones have been
observed corresponding at the physiological level, in dif-
ferences in secretion and absorption activities.
RNA extraction
Frozen tissue (150 to 200 mg) was homogenized in 2 ml
of Tri-Reagent (Sigma, St Quentin Fallavier, France) using
an Ultra-Turrax. The RNA extraction was performed
according to the manufacturer's instructions with small
modifications. A second extraction was performed on the
aqueous phase to optimize the RNA quality. For all sam-
ples, RNA quantity and quality were measured by absorb-
ance ratio at 260/280 nm (NanoDrop, Thermo Fisher
Scientific, Villebon-sur-Yvette, France) and the integrity of
the mRNAs was determined by both standard agarose gels
and mRNA-chip gel system using an Agilent Bioanalyzer
(Agilent Technologies, Massy, France). Only samples
passing these tests were kept and for sample that failed,
extraction was redone on a different piece of sample in
order to meet these criteria of quality.
cDNA microarray
The set up of the AGENAE cDNA library and of the 9 K
cDNA nylon microarray used in this study has been pub-
lished in detail previously [30]. The microarrays were
obtained from the resource centre GADIE (INRA-Jouy-en-
Josas, France). Briefly, a pig multi-tissue cDNA library
from 38 tissues was used to generate the cDNA microar-
ray. The libraries were constructed, normalized and sub-
tracted following the protocol of Soares et al., [101]. 8931
different pig clones were selected either from the gener-
ated multi-tissue library (7749), or USDA clones (835) or
from different homemade libraries (347). The cDNA
clones obtained after PCR amplification were spotted
onto Hybond N+ membranes (7.5 × 2.5 cm) as previously
described [102]. Controls were also included: 78 controls
(64 waters and 14 empty wells), 195 spikes (193 luci-
ferase, 2 Arabidopsis thaliana clones) and 12 empty-vec-
tor controls. The array is published on the site Gene
Expression Omnibus http://www.ncbi.nlm.nih.gov/geo/
under the reference number GPL3729.
Labeling and hybridization
Forty-eight RNA samples originating from the four ani-
mals were used for microarray hybridization according to
the following procedure. A first hybridization was per-
formed using a 33P-labelled 19-mer oligonucleotide
(CACTATAGGGAATTTGGCC), which matches a
sequence present at the extremity of each PCR product to
estimate the amount of cDNA dropped on each spot.
Only membranes with a good pattern of spotting were
retained and were attributed at random for the hybridiza-
tion with the 33P-cDNA from the tissues. After stripping (3
hours 68°c, 0.1× SSC, 0.2% SDS), hybridizations were
carried out as previously described [103], with minor
modifications. Arrays were prehybridized for 4 hours atBMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
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65°C in hybridization solution (5× Denhardt's, 5× SSC,
0.5% SDS). Labelled cDNA probes were prepared from 5
μg of RNA by simultaneous reverse transcription and labe-
ling for 2 hours at 42°C in the presence of 30 μCi alpha
33P-dCTP, 2.4 μM dCTP, 0.4 mM each dATP, dTTP, dGTP,
40 units RNasin® Ribonuclease Inhibitor (Promega, Char-
bonnières-les-Bains, France) and 200 units MMLV Super-
Script RNase H-reverse transcriptase (Gibco-BRL, Cergy
Pontoise, France) in 30 μL final volume. RNAs were
degraded by treatment at 68°C for 20 min with 1 μL 10%
SDS, 1 μL 0.5 M EDTA and 3 μL of 3 M NaOH, and then
equilibrated at room temperature for 10 min. Neutraliza-
tion was done by adding 10 μL 1 M Tris-HCl, 3 μL 2 N
HCl, 2 μL of an 80 polyA oligomers (1 μg. μl-1) and 50 μL
of hybridization solution then by incubating during 5
min at 99°C and 1 hour at 65°C.
Arrays were then incubated with the corresponding dena-
tured labeled cDNA for 18 h at 65°C in hybridization
solution. After 3 washes (1 hours 68°C, 0.1× SSC, 0.2%
SDS), they were exposed to phosphor-imaging plates (24
or 48 hours) before scanning using a FUJI BAS 5000 (Fuji-
film France, St. Quentin en Yvelines, France). Each array
image was inspected using AGScan software [104,105] to
eliminate (flag) "bad" spots and artifacts (dust, etc.) from
the analysis. Signal intensities were then automatically
quantified. One of the advantages to use radiolabeled
complex probes is that they allow detecting very low-
expressed mRNAs even when using small total RNA
amounts [102,103].
Microarray data processing
Spots for which the vector oligonucleotide data had inten-
sities lower than a cut-off value established as a mean level
intensity of water control spots plus 3 times the standard
error deviation were excluded from analysis. This cut-off
value was calculated for each microarray independently.
Then data corresponding of all hybridizations (vector and
labeled cDNA) were log2-transformed, normalized by the
median of intensities by block then by array. Finally, sig-
nal processing was performed using vector oligonucle-
otide data to correct the relative amount of cDNA present
in each spot. The microarray data from this research has
been deposited in the NCBI Gene Expression Omnibus
data repository under accession number GSE15614.
Statistical analysis
Statistical analyzes were performed using the R software
version 2.4.1 (R Development Core Team, 2006) and
packages that can be downloaded either from the CRAN
or the BioConductor site http://www.bioconductor.org/.
a) Search for differentially expressed transcripts
The search for differentially expressed transcripts had two
purposes: first, find transcripts that clustered our data and
second, find transcripts that were preferentially over-
expressed in a particular condition (See flowchart, Addi-
tional File 7). Detection of these differentially expressed
genes relies on statistical tests, typically t-tests, but these
tests have in general low power for microarray analysis
due to the lack of information on each individual gene
[106]. A key and critical aspect of these tests is the mode-
ling of the residual variances. To get the most information
from our data, we decided to detect differentially
expressed genes using tests based on variance modeling:
the Limma for moderated F-tests based on a hierarchical
Bayesian method [107] and the SMVar method for pair-
wise comparisons with moderated t-tests based on a struc-
tural model [31].
To determine differentially expressed transcripts between
12 samples (testis, vas efferens, nine epididymal zones, vas
deferens) or between 10 samples (the nine epididymal
zones and deferent duct), the moderated F-test available
in the Limma R package was used [108]. To account for
dependencies between the data from the same animal, an
animal effect was included in the model. Then, in order to
determine transcripts preferentially over-expressed in one
particular condition (tissue), we searched iteratively for
transcripts differentially expressed between 2 conditions
with a moderated t-test of the SMVar R package [31]. To
define a differentially expressed gene between 2 condi-
tions, the difference of mean intensity between the 2 con-
ditions and the variance were calculated to obtain a ratio
of these 2 values (mean and variance). If this ratio is
"high", the gene is considered as differentially expressed.
SMVar improves the estimation of the variance for small
number of replicates like in this study. This method is a
"shrinkage" approach, that takes into account informa-
tion from all the genes to estimate each individual gene
statistic. This increases the sensitivity of the test since the
numbers of parameters to estimate is decreased. Its origi-
nality resides in the fact that the program models one var-
iance per condition and not directly the variance of the
difference between the two conditions. Thus, it allows for
heterogeneous variances between conditions. More expla-
nation could be found in Jaffrezic et al, [31]. In both anal-
yses, a Benjamini & Hochberg [109] correction was
performed on the raw p-values to correct for multiple
tests.
b) Clustering of tissue arrays and transcripts
Clustering is useful for organizing the genes and samples
from a set of microarray experiments so as to reveal bio-
logically interesting patterns. There are several possibili-
ties to cluster microarray data; among them agglomerative
(bottom-up) hierarchical clustering algorithms are the
most commonly used. Hierarchical methods are espe-
cially useful, because they enable to simultaneously exam-
ine groupings of the data into many small clusters (e.g.BMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
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repeat samples from the same tissue) and a few large clus-
ters (e.g. different treatment groups). The use of a single
hierarchical model ensures that groups at different levels
are nested, facilitating interpretation. Bottom-up cluster-
ing, which successively joins objects, is good at identifying
small clusters, but can provide sub-optimal performance
for identifying some large clusters. Conversely, top-down
methods are good at identifying a few large clusters, but
weaker when there are many small clusters. Because we
had no a priori about the size of clusters from our data we
analyzed our data with one algorithm of each of these two
methods of clustering.
We then defined an original combination of statistical
methods using: (1) a hierarchical method (Hierarchical
Ascendant Classification: HAC or Hierarchical Clustering:
HCL) and (2) a partitioning method (Partitioning around
medoid: PAM). The hierarchical method is an unsuper-
vised method: the analysis of the data is done without any
a priori on the number of classes expected, but a major
weakness of the hierarchical algorithm is that an improper
fusion of data at an early stage cannot be corrected later.
In order to correct this weakness, at least partially, we
decided to add a second clustering step with the partition-
ing method. We choose the PAM algorithm because, com-
pared to the k-means approach, it: (a) accepts a
dissimilarity matrix (missing values allowed), (b) is more
robust as it minimizes a sum of dissimilarities instead of
a sum of squared Euclidean distances, (c) provides a
graphical display, the silhouette plot, which allows the
user to select the optimal number of clusters [110]. The
PAM algorithm is classically used as a supervised method,
but we used it as a "mixed unsupervised" method by giv-
ing a range of possible numbers of classes instead of a
fixed one. This way, the PAM defines itself the best
number of classes that fit our data. Note that the objects
(zones or transcripts) similarity metric was the 1 minus
correlation-based distance. On the other hand, the crite-
rion chosen to agglomerate two clusters was the Ward cri-
terion that consists in merging two clusters with a
minimum increases in the total. The tissues clustering,
allowed us to obtain "transcriptomic units" defined as
association of zones in which the most differential tran-
scripts have the same expression profile. But this classifi-
cation is not informative about transcripts. Therefore, we
made transcripts clustering that found clusters of co-
expressed transcripts. According to expression profile of
transcripts in each cluster, it was possible to conclude that
clusters contain transcripts preferentially expressed in
some of the transcriptomic units defined previously but
not in all.
Tissues clustering
To identify some transcriptomic units defined by the
agglomeration of membrane arrays inside of which the
majority of the studied transcripts have similar expression
profiles, we used the list of differentially expressed tran-
scripts obtained from the Limma analysis. To determine
the number of classes for which our data are the best clas-
sified, we used the PAM from the Cluster R package [108].
The PAM gives a score for a defined number of classes. We
also performed the classification with the hierarchical
algorithm, the HAC, present in the same package and only
the results common for both methods were kept.
Transcripts clustering
The aim of this analysis was to identify some characteristic
evolution of gene regulation between the different tissues
studied. This classification was performed similarly as the
zone clustering, using the list of differentially expressed
transcripts obtained with the Limma package.
Sequence annotation
a) Nucleotidic information
Because pig genome is not yet entirely sequenced and
assembled, in order to obtain the name of the gene coding
for the cDNA clones spotted on the microarray and hence
the maximum of physiological information, we have
compared the complete (when available) or partial
sequence (EST) of clones with the NCBI UniGene
"unique" database (defined as the "longest, best"
sequence from each UniGene cluster) of different mam-
malian species. cDNA sequences were compared to Uni-
Gene Sus scrofa (Build #33), Homo sapiens (Build #213),
Bos Taurus (Build #92), Mus musculus (#173), Rattus nor-
vegicus (Build #175) and Canis familiaris (Build #22) using
BLASTN (v2.2.18) [111]. Two criteria depending on the
database were used to parse and filter the blast results: For
Sus scrofa database, we kept only sequences (subjects)
with a global High-scoring Segment Pair (HSP) length of
at least 200 nucleotides and 80% of identities with the
cDNA sequence (query). For other databases, only
sequences with a global HSP length of at least 200 nucle-
otides and 70% identities with the cDNA sequence were
kept. For EST sequences with a length around 200 nucle-
otides that were still not annotated, we used the following
criteria to filter their blast results: for Sus scrofa database,
we kept only sequences with a minimum global coverage
of 50% of the cDNA sequence with 80% of identities. For
other databases, we kept only sequences with a minimum
global coverage of 50% of the cDNA sequence with 70%
of identities. Then for cDNA sequences that pass these fil-
ters, we kept the UniGene ACC corresponding to the
sequence with the best score for each species to annotate
the corresponding clone.
b) Protein information
The UniGene ACC were further used to obtain the corre-
sponding UniProt ACC using the ID Mapping tool on the
UniProt web site http://www.uniprot.org/. When a Uni-BMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
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Gene ACC mapped to several UniProt ACC, we kept the
one corresponding to the SwissProt databank. These Uni-
Prot ACC were used to annotate the corresponding clone.
c) Biological network and pathway analysis
Gene ontology annotations associated to the UniProt
ACC were obtained on the Gene Ontology Annotation
(GOA) Database http://www.ebi.ac.uk/GOA/.
Gene Ontology term enrichment
To have the maximum information, we worked with a
multi-species approach. For each clone, we have kept the
Gene Ontology information available for the UniProt
ACC corresponding to the Homo UniGene ACC hit, oth-
erwise we have kept the Gene Ontology information avail-
able for the UniProt ACC corresponding to the mouse
UniGene ACC, then to the rat, then to the bovine, to the
dog and at least the pig. The Gene Ontology term enrich-
ment analysis was done with the data corresponding to
transcripts clustered by classification analyses with 12 and
10 tissues for the 3 main GO terms independently (Bio-
logical process, Cellular component and Molecular func-
tion). For each cluster, we have retained a unique UniProt
ACC (to eliminate multiple spotted genes). We have
searched for Gene Ontology terms that were enriched in
one cluster compare to all the clusters obtained by the
classification analyses with 12 and 10 zones using EASE
program [112]. A Benjamini & Hochberg [109] correction
was performed on the raw p values to correct for multiple
tests for each Gene Ontology term. A term was defined as
significantly enriched when it had an adjusted p-value
lower or equal to 15%.
Validation of microarray Results by PCR and Q-PCR
a) PCR
The reverse transcriptase assay was performed on 3 μg
total RNA using the Superscript Reverse transcriptase H
(Invitrogen, Cergy Pontoise, France) and oligo(dT)15
primers. PCR was performed at the temperature specified
for the primer sets (see Additional File 2) and a final elon-
gation step at 72°C for 5 min. Aliquots of each reaction
mixture were analyzed on a 2% ethidium bromide stained
agarose gel. PCRs on tissues were performed for 25, 30, 35
and 40 cycles. RPL19  primers (Additional File 2) were
used as PCR controls and to correct the quantity of mRNA
after digital analysis of the signal. For all amplicons,
sequencing was done at least once in order to validate the
primers.
b) QPCR
For each set of primers (Additional File 8) a standard
curve was constructed using a serial dilution of cDNA
solution. These curves were generated using dilution coef-
ficient versus the mean threshold cycle (Ct). The linear
correlation coefficient (R2) ranged from 0.97 to 0.99.
Based on the slopes of the standard curves, the amplifica-
tion efficiencies of the standards ranged from 1.8~2.2,
(derived from the formula E = EXP(-1/slope)). This calcu-
lation method results in efficiencies higher than 100%,
which was an overestimate of the "real efficiency". Each
PCR reaction also included a non-template negative con-
trol to check for primer-dimer. Each reaction consisted of
20 μL containing 3 μL of cDNA (diluted 5 times) and 9
pmol of each primer set. The real time qPCR was run on a
iCycler system (Bio-Rad, Marnes-la-Coquette, France).
The cycling conditions were 1 cycle of denaturation at
95°C/3 min, followed by 40 three-segment cycles of
amplification (95°C/30 sec, 58°C/30 sec, 72°C/20 sec)
where the fluorescence was automatically measured dur-
ing elongation and melting steps (80 cycles of 30 sec with
a temperature range from 55 to 96°C). The baseline
adjustment method of the iCycler system software (Bio-
Rad, version 3.1) was used to determine the Ct in each
reaction. A melting curve was constructed for each primer
pair to verify the absence of dimerization. All samples
were amplified in duplicates and the mean was used for
further analysis. To compare expression level of a gene
between different tissues studied, the mean Ct of each
sample was corrected by this obtained for RPL19.
Comparison between mammalians transcriptomic data
A comparison of epididymal transcriptomic data
obtained for mouse, rat, human and boar was realized.
For mouse and rat, expression dataset were downloaded
from the Mammalian Reproductive Genetics website
http://mrg.genetics.washington.edu/ and annotation files
were obtained from Affymetrix website. For mouse, we
used the same criterion as in Johnston et al. [21] to con-
sider qualified genes. Then, mouse UniGene IDs corre-
sponding to Affymetrix IDs was obtained (this represents
14418 ID). For rat, we applied the criterion defined by
Jelinsky et al. [20] to consider qualified genes. Then, we
obtained the rat UniGene IDs corresponding to Affyme-
trix IDs (15072 IDs). These rat UniGene IDs were trans-
formed in mouse homologous UniGene ID using NCBI E-
Utilities. We then obtained 11008 homologous mouse
Unigene IDs.
For human, the list of genes considered detectable in the
epididymis from Thimon et al. [22] study was kindly pro-
vided to us by Dr Sullivan (Université Laval, Québec, Can-
ada). Then, human UniGene IDs corresponding to
Affymetrix IDs for qualified genes were obtained using
annotation file downloaded from the Affymetrix website
(34097 ID). As for rat, we have obtained corresponding
mouse UniGene ID (final list: 23774 ID). For boar, weBMC Genomics 2009, 10:369 http://www.biomedcentral.com/1471-2164/10/369
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used transcripts that were differentially expressed between
the 12 and 10 conditions for which we have been able to
associate UniGene IDs (mouse, human, rat, bull, dog and
boar). Using NCBI E-Utilities, we obtained 1550 homolo-
gous mouse UniGene ID.
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Additional file 1
List of potential markers for each of the 7 transcriptional units. For 
each transcript defined as potential marker, the first column gives the 
transcriptional unit for which it was found to be a potential marker, the 
second gives its index on the array, columns 3 and 4 show the UniGene 
ACC and UniGene definition obtained by BLAST and column 5 shows its 
mean intensity measured for the transcriptional unit of interest.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-369-S1.xls]
Additional file 2
Gene-specific primers used for PCR study. For each primer pair is given 
the Gene Symbol, the Gene name, sequences of forward and reverse prim-
ers, the length of amplified fragment, the GenBank Accession of the 
sequence used to design primers and the EMBL Accession of the sequenced 
amplified fragment.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-369-S2.pdf]
Additional file 3
Transcripts corresponding to analysis of Gene Ontology term enrich-
ment for clustering with 12 tissue samples. For each GO term defined 
as enriched, the first column gives its definition, columns 2 and 3 show its 
GO ID and the class it belongs to (B_P: Biological Process, C_C: Cellular 
Component and M_F: Molecular Function). Column 4 gives the tran-
script cluster in which it was enriched. The last 5 columns show the index 
on the array, UniGene ACC, UniProtKB ACC, UniprotKB ID and Uni-
protKB definition of transcripts corresponding to GO terms enriched, 
respectively.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-369-S3.xls]
Additional file 4
Transcripts corresponding to analysis of Gene Ontology term enrich-
ment for clustering with 10 tissue samples. For each GO term defined 
as enriched, the first column gives its definition, columns 2 and 3 show its 
GO ID and the class it belongs to (B_P: Biological Process, C_C: Cellular 
Component and M_F: Molecular Function). Column 4 gives the tran-
script cluster in which it was enriched. The last 5 columns show the index 
on the array, UniGene ACC, UniProtKB ACC, UniprotKB ID and Uni-
protKB definitions of transcripts corresponding to GO terms enriched, 
respectively.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-369-S4.xls]
Additional file 5
Common over-expressed genes in the same epididymal unit between 
mammal species (Sus scrofa, Mus musculus, Rattus norvegicus and 
Homo sapiens). For each gene found over-expressed in the same epididy-
mal unit between the 4 species, column 1 gives the unit for which it was 
found to be over-expressed. Column 2 shows its index on the pig array and 
the last 2 columns give its UniGene ACC and UniGene definition in 
mouse species.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-369-S5.xls]
Additional file 6
List of boar potential markers for which a knockout has a reproductive 
effect on mouse (MGI database). For each potential marker for which a 
knockout has a reproductive effect on the mouse, column 1 gives the tran-
scriptional unit for which it is a potential marker. Column 2 shows the 
UniGene ACC corresponding to this marker used to obtain the 
Mouse.Ensembl.Gene.ID (column 3). Column 4 gives the MGI ACC 
associated with the marker and columns 5 and 6 show the symbol and the 
name of this marker, respectively. The last column gives a short description 
of the reproductive system phenotype.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-369-S6.xls]
Additional file 7
Statistical methods. This flowchart summarizes our statistical methods in 
3 steps. First (in blue), we search for differentially expressed transcripts 
between our 12 or 10 tissue samples in order to discover the classes of co-
expressed transcripts and transcriptional units. Results of sample classifi-
cation were used to search for over-expressed transcripts in a single tran-
scriptional unit (orange). Finally, potential markers were transcripts 
which were common for one unit in cluster and over-expressed lists (pur-
ple).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-369-S7.pdf]
Additional file 8
Gene-specific primers used for realtime PCR study. For each primer 
pair is given the Gene Symbol, the Gene name, sequences of forward and 
reverse primers, the length of amplified fragment and the GenBank Acces-
sion of the sequence used to design primers.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
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